Sprycel (Dasatinib) for Philadelphia Chromosome-Positive Leukemia

Sprycel contains dasatinib, a targeted tyrosine kinase inhibitor used for selected Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) and acute lymphoblastic leukemia (Ph+ ALL). Dasatinib blocks BCR-ABL signaling and other kinases that help leukemia cells grow. Treatment selection, dose changes, and follow-up must be directed by a hematology-oncology team.

• Uses: specialist-directed treatment of Ph+ CML and certain Ph+ ALL.
• Class: BCR-ABL tyrosine kinase inhibitor.
• Schedule: usually taken once daily exactly as prescribed.
• Monitoring: blood counts, liver function, fluid retention, and cardiopulmonary symptoms need regular review.

How does Sprycel work?

Dasatinib inhibits the abnormal BCR-ABL tyrosine kinase created by the Philadelphia chromosome. This pathway drives the uncontrolled growth of leukemia cells. It may also inhibit other kinases, which contributes to therapeutic effects and to some adverse reactions. Response is assessed through specialist blood testing and molecular monitoring; do not stop treatment because symptoms improve or laboratory results change without oncology advice.

How should Sprycel be taken?

Take Sprycel with or without food at the same time each day and swallow tablets whole. Do not crush, split, chew, or dissolve them unless the oncology team gives a specific alternative instruction. Confirm the prescribed strength before you buy Sprycel 20 mg, buy Sprycel 50 mg, or buy Sprycel 100 mg. If a dose is missed, follow the care team’s directions; do not take an extra dose to compensate.

What are the common and serious side effects of Sprycel?

Fatigue, headache, nausea, diarrhea, rash, muscle or joint pain, and fluid retention can occur. Dasatinib can also lower white blood cells, red blood cells, and platelets, increasing infection, anemia, and bleeding risks. Contact the oncology team promptly for fever, chills, unusual bruising, bleeding, black stools, severe tiredness, shortness of breath, rapid weight gain, chest pain, or swelling of the hands, feet, or face.

Serious reactions can include pleural effusion, pulmonary arterial hypertension, heart problems, severe bleeding, liver injury, and severe skin reactions. Sudden breathing difficulty, fainting, coughing blood, severe chest symptoms, or an irregular heartbeat requires urgent medical care.

What medicines and foods interact with Sprycel?

Tell the oncology team about every prescription medicine, over-the-counter product, and supplement. Strong CYP3A4 inhibitors, such as ketoconazole, itraconazole, clarithromycin, ritonavir, and grapefruit products, may increase dasatinib exposure. CYP3A4 inducers, including rifampin, carbamazepine, phenytoin, and St John’s wort, may reduce its effect. Antacids, H2 blockers, and proton-pump inhibitors can interfere with absorption; the clinician or pharmacist can provide a timing plan.

Who needs special precautions with Sprycel?

Individual assessment is important for people with heart disease, arrhythmia, lung disease, prior pleural effusion, liver impairment, bleeding disorders, or low blood counts. Pregnancy and breastfeeding require specialist guidance because dasatinib may harm a developing fetus or nursing infant. Keep all scheduled blood tests and appointments, and discuss vaccinations and infection precautions with the care team.

What should I know before ordering Sprycel?

Use a current oncology prescription and an authorized specialty pharmacy. Sprycel price may vary by strength, supply duration, insurance coverage, and dispensing requirements. Comparing Sprycel price should not replace molecular monitoring, interaction screening, and verified medication handling. A very low Sprycel price is not proof of legitimate supply; do not decide to buy Sprycel from an unverified seller.

Store tablets in their original container as labeled, away from moisture and out of the reach of children. This information is general educational content and cannot replace the individualized treatment plan from your oncology team.